tirzepatide type 1 diabetes trial Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with 2 (SURPASS-1): a double-blind, randomised, phase 3 A Study of Tirzepatide (LY3298176)

doi: 10.1016/j.apsb.2020.05.006 38 RajVSMouHHSmitsSLDekkersDHWMllerMADijkmanRet al

While serious interactions are rare, individualized assessment ensures optimal safety, particularly in patients with complex medication regimens or multiple comorbidities common in the population prescribed semaglutide for diabetes or weight management

Precautions During Treatment Monitor EPO Sensitivity: As anemia improves, the nephrology team must be prepared to down-titrate EPO doses to prevent polycythemia (excessively high red blood cell counts)

Safety data in humans is not as robust as it is for FDA approved medications

A.JaeschkeH.MarenziG.RicheldiL.et al

As it comes in powder form, firstly, you need to mix semaglutide with bacteriostatic water